Regeneron Pharmaceuticals (REGN) stock forecast for 2022. Forecast tables and graphs.

Regeneron Pharmaceuticals (REGN) stock forecast for 2022

Last update: October 3, 2022 (05:51)

Sector: Healthcare

The share price of Regeneron Pharmaceuticals, Inc. (REGN) now

What analysts predict:: $749.04

52-week high/low: $754.67 / $538.01

50/200 Day Moving Average: $637.25 / $636.81

This figure corresponds to the average price over the previous 50/200 days. For Regeneron Pharmaceuticals stocks, the 50-day moving average is the resistance level today.

For Regeneron Pharmaceuticals stocks, the 200-day moving average is the resistance level today.

Are you interested in Regeneron Pharmaceuticals stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Regeneron Pharmaceuticals stock price in 2022. How much will one Regeneron Pharmaceuticals share be worth in 2022?

Is it worth taking profit / loss on Regeneron Pharmaceuticals stock now or waiting? What are analysts' forecasts for Regeneron Pharmaceuticals stock?

We forecast Regeneron Pharmaceuticals stock performance using neural networks based on historical data on Regeneron Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

The Regeneron Pharmaceuticals stock prediction results are shown below and presented as a graph, table and text information.

Regeneron Pharmaceuticals stock forecasts are adjusted once a day based on the closing price of the previous trading day.

The minimum target price for Regeneron Pharmaceuticals analysts is $749.04.

Today 200 Day Moving Average is the resistance level (636.81 $).

50 Day Moving Average is the resistance level (637.25 $).





Historical and forecast chart of Regeneron Pharmaceuticals stock

The chart below shows the historical price of Regeneron Pharmaceuticals stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Regeneron Pharmaceuticals stock price can be found in the table below.

Regeneron Pharmaceuticals (REGN) Forecast for 2022

Month Target Pes. Opt. Vol., %
Nov 698.17 681.83 742.15 8.13 %
Dec 713.88 670.19 741.51 9.62 %

Regeneron Pharmaceuticals information and performance

Regeneron Pharmaceuticals, Inc. is an American biotech company headquartered in Eastview, near Tarrytown, New York. The company was founded in 1988. Initially, it focused on neurotrophic factors and their regenerative capabilities (hence the name), and then branched out into the study of both cytokine and tyrosine kinase receptors.

Regeneron Pharmaceuticals Address

777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, US

Market Capitalization: 75 092 337 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: 7 376 800 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: 13.84

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 4.638

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 49.76

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: -0.733

Quarterly Revenue Growth YOY: -0.444

Trailing PE: 13.84

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 14.27

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 4.959

Enterprise Value (EV) /Revenue

EV To EBITDA: 10.54

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 107190000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A

Regeneron Pharmaceuticals price target for 2021 by month


Target values for the price of one Regeneron Pharmaceuticals share for Nov 2022.

The weighted average target price per Regeneron Pharmaceuticals share in Nov 2022 is: 698.17. In Nov, the positive dynamics for Momo shares will prevail with possible monthly volatility of 8.128% volatility is expected.

Pessimistic target level: 681.83

Optimistic target level: 742.15


Target values for the price of one Regeneron Pharmaceuticals share for Dec 2022.

The weighted average target price per Regeneron Pharmaceuticals share in Dec 2022 is: 713.88. In Dec, the positive dynamics for Momo shares will prevail with possible monthly volatility of 9.618% volatility is expected.

Pessimistic target level: 670.19

Optimistic target level: 741.51




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.